A calcium sensitizer
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Levosimendan

Item No. 16128

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-[2-[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazinylidene]-propanedinitrile
CAS Number
141505-33-1
Synonyms
  • OR 1259
  • (R)-Simendan
Molecular Formula
C14H12N6O
Formula Weight
280.3
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 25 mg/mlEthanol: 10 mg/ml
λmax
290, 382 nm
SMILES
O=C1C[C@@H](C)C(C2=CC=C(N/N=C(C#N)\C#N)C=C2)=NN1
InChi Code
InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1
InChi Key
WHXMKTBCFHIYNQ-SECBINFHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    50 mg

    $63

    Add

    100 mg

    $96

    Add

    250 mg

    $215

    Add

    500 mg

    $387

    Add
    Product Description

    Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C (EC50 = 9 nM), promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells (EC50 = 0.28 µM), and performs a cardioprotective function by prompting the opening of mitochondrial potassium channels in cardiomyocytes.1,2 It also has been reported to inhibit phosphodiesterases 3 and 4 in left ventricular cardiac tissue with IC50 values of 2.5 nM and 25 µM, respectively.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nieminen, M.S., Fruhwald, S., Heunks, L.M.A., et al. Levosimendan: Current data, clinical use and future development. Heart Lung Vessel 5(4), 227-245 (2013).

    2. Papp, Z., Csapó, K., Pollesello, P., et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc. Drug Rev. 23(1), 71-98 (2005).

    3. Szilágyi, S., Pollesello, P., Levijoki, J., et al. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phophodiesterase enzymes of the guinea pig. Eur. J. Pharmacol. 486(1), 67-74 (2004).